Victoria Butners
Dermavant Sciences GmbH
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Victoria Butners as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 05:14 UTC. Open this list on ClinicalTrials.gov
- Ph3NCT04053387 · Long Term Extension Study of Tapinarof for Plaque Psoriasis in Adults (3003)Organon and Co · completed · Plaque Psoriasis · study director
- Ph3NCT03983980 · Tapinarof for the Treatment of Plaque Psoriasis in Adults (3002)Organon and Co · completed · Plaque Psoriasis · study director
- Ph3NCT03956355 · Tapinarof for the Treatment of Plaque Psoriasis in Adults (3001)Organon and Co · completed · Plaque Psoriasis · study director
Grants
NIH projects from RePORTER, fetched 2026-11-12 05:14 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 05:14 UTC. The ranking covers the 200 most relevant of 2 PubMed records, and a shared surname and initials can bring in a namesake. All 2 on PubMed
- Evaluation of the efficacy, tolerability, and safety of an over-the-counter acne regimen containing benzoyl peroxide and salicylic acid in subjects with acne.J Drugs Dermatol · 20137 citationsRCR 0.5
- Long-term safety of ketoconazole foam, 2% in the treatment of seborrheic dermatitis: results of a phase IV, open-label studyJ Drugs Dermatol · 20133 citationsRCR 0.2